Canada Life’s Amicus Therapeutics FOLD Stock Holding History

Canada Life’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$731K	Buy	50,425 +6,747	+15%	+$96.7K	﹤0.01%	1428
2025 Q4	$622K	Sell	43,678 -40,867	-48%	-$401K	﹤0.01%	1468
2025 Q3	$671K	Buy	84,545 +781	+0.9%	+$5.56K	﹤0.01%	1541
2025 Q2	$480K	Buy	83,764 +2,263	+3%	+$14.6K	﹤0.01%	1616
2025 Q1	$666K	Buy	81,501 +1,425	+2%	+$13.2K	﹤0.01%	1546
2024 Q4	$753K	Buy	80,076 +5,522	+7%	+$57.4K	﹤0.01%	1542
2024 Q3	$798K	Sell	74,554 -10,550	-12%	-$115K	﹤0.01%	1569
2024 Q2	$843K	Sell	85,104 -15,434	-15%	-$158K	﹤0.01%	1538
2024 Q1	$1.18M	Buy	100,538 +7,304	+8%	+$93.4K	﹤0.01%	1459
2023 Q4	$1.31M	Buy	93,234 +5,122	+6%	+$58.2K	﹤0.01%	1423
2023 Q3	$1.07M	Sell	88,112 -555	-0.6%	-$7.16K	﹤0.01%	1453
2023 Q2	$1.12M	Buy	88,667 +6,749	+8%	+$80.1K	﹤0.01%	1461
2023 Q1	$910K	Sell	81,918 -4,138	-5%	-$51K	﹤0.01%	1538
2022 Q4	$1.05M	Buy	86,056 +48,884	+132%	+$550K	﹤0.01%	1500
2022 Q3	$387K	Buy	37,172 +23,887	+180%	+$266K	﹤0.01%	1737
2022 Q2	$143K	Buy	13,285 +649	+5%	+$5.34K	﹤0.01%	1866
2022 Q1	$127K	Buy	12,636 +617	+5%	+$5.79K	﹤0.01%	1946
2021 Q4	$139K	Buy	12,019 +588	+5%	+$6.55K	﹤0.01%	1941
2021 Q3	$110K	Hold	11,431	–	–	﹤0.01%	2035
2021 Q2	$110K	Sell	11,431 -2,509	-18%	-$24.5K	﹤0.01%	2064
2021 Q1	$137K	Sell	13,940 -4,146	-23%	-$64.2K	﹤0.01%	2030
2020 Q4	$417K	Hold	18,086	–	–	﹤0.01%	1797
2020 Q3	$255K	Hold	18,086	–	–	﹤0.01%	1836
2020 Q2	$271K	Hold	18,086	–	–	﹤0.01%	1828
2020 Q1	$168K	Hold	18,086	–	–	﹤0.01%	1855
2019 Q4	$175K	Buy	18,086 +4,450	+33%	+$40.7K	﹤0.01%	1951
2019 Q3	$109K	Sell	13,636 -12,064	-47%	-$131K	﹤0.01%	1005
2019 Q2	$320K	Buy	25,700 +89	+0.3%	+$1.13K	﹤0.01%	1913
2019 Q1	$347K	Buy	25,611 +5,117	+25%	+$62.5K	﹤0.01%	1739
2018 Q4	$189K	Hold	20,494	–	–	﹤0.01%	1951
2018 Q3	$248K	Hold	20,494	–	–	﹤0.01%	1923
2018 Q2	$320K	Buy	20,494 +5,148	+34%	+$77.8K	﹤0.01%	1845
2018 Q1	$231K	Sell	15,346 -6,935	-31%	-$106K	﹤0.01%	1923
2017 Q4	$320K	Buy	22,281 +7,836	+54%	+$108K	﹤0.01%	1846
2017 Q3	$212K	Buy	14,445 +4,145	+40%	+$54.8K	﹤0.01%	1933
2017 Q2	$103K	Hold	10,300	–	–	﹤0.01%	2111
2017 Q1	$73K	Hold	10,300	–	–	﹤0.01%	2204
2016 Q4	$51K	Hold	10,300	–	–	﹤0.01%	2319
2016 Q3	$76K	Hold	10,300	–	–	﹤0.01%	2239
2016 Q2	$56K	Hold	10,300	–	–	﹤0.01%	2278
2016 Q1	$87K	Hold	10,300	–	–	﹤0.01%	1877
2015 Q4	$100K	Hold	10,300	–	–	﹤0.01%	1759
2015 Q3	$144K	Hold	10,300	–	–	﹤0.01%	1439
2015 Q2	$145K	Hold	10,300	–	–	﹤0.01%	1583
2015 Q1	$111K	Buy	+10,300	New	+$90.8K	﹤0.01%	1736

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Canada Life's FOLD Position: Q1 2026 in Review

Canada Life increased its Amicus Therapeutics (FOLD) stake by 15% in Q1 2026, buying an estimated $96.7K and bringing the position to 50,425 shares worth $731K. The position accounts for ﹤0.01% of the portfolio, ranked #1428.

Canada Life first reported a position in FOLD in Q1 2015 and has held it in 45 quarters since. The position peaked at $1.31M in Q4 2023. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Canada Life held 50,425 shares of Amicus Therapeutics worth $731K as of Q1 2026.
Canada Life bought 6,747 Amicus Therapeutics shares in Q1 2026, an estimated $96.7K.
Amicus Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1428 holding.
Canada Life first reported a position in Amicus Therapeutics in Q1 2015 and has held it in 45 quarters since.
Canada Life's Amicus Therapeutics position peaked at $1.31M in Q4 2023.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.